Literature DB >> 14687624

Elevated expression of a subset of interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis.

Anjali S Advani1, Holly K Dressman, Marisol Quiroz, Gregory A Taylor, Ann Marie Pendergast.   

Abstract

p185 Bcr-Abl has a more aggressive biological/clinical leukemia phenotype than p210 Bcr-Abl. In this study, we examined differential gene expression using microarrays to determine if upregulation or downregulation of specific genes may explain the distinct phenotypes produced by the two Bcr-Abl forms. RNA was collected from mouse bone marrow mononuclear cells expressing equivalent levels of p185 or p210, and the RNAs were subjected to microarray analysis. Significant differences in gene expression were observed on hierarchical clustering. A group of interferon-gamma-inducible genes, including those encoding a family of 47 kDa GTPases, were significantly increased in p185 versus p210. This family of GTPases has previously been implicated in interferon-gamma-induced resistance against intracellular pathogens, however their exact cellular functions are unknown. Our data suggest that their increased expression may contribute to the biological/clinical phenotype associated with p185.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687624     DOI: 10.1016/s0145-2126(03)00264-9

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  The mouse resistance protein Irgm1 (LRG-47): a regulator or an effector of pathogen defense?

Authors:  Julia P Hunn; Jonathan C Howard
Journal:  PLoS Pathog       Date:  2010-07-15       Impact factor: 6.823

2.  Tyrosine kinase chromosomal translocations mediate distinct and overlapping gene regulation events.

Authors:  Hani Kim; Lisa C Gillis; Jordan D Jarvis; Stuart Yang; Kai Huang; Sandy Der; Dwayne L Barber
Journal:  BMC Cancer       Date:  2011-12-28       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.